Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.
Here’s How the Novavax COVID Shot Held Up Against Omicron
During the 2022 Omicron wave, Novavax’s protein-based COVID shot had an estimated 50% vaccine effectiveness (VE) against symptomatic infection in fully vaccinated people and a
October 5, 2023